leadf
logo-loader
AIM:REDX FRA:0RX

Redx Pharma PLC

Receive alerts
Market:
AIM
Market Cap:
£171.18 m
Price
62.50 GBX
Change
0.00%
52 weeks high
94.95
52 weeks low
4.50

In brief

Redx is a biotech company focused on the discovery and development of novel targeted medicines for the treatment of cancer and fibrotic disease, aiming to progress them to clinical proof of concept (PoC).

Snapshot

  • Cancer drug in the clinic 
  • Promising fibrosis treatments targeting large markets
  • Deals with AstraZeneca and Jazz Pharmaceuticals